Beryl Capital Management’s Immune Design Corp. IMDZ Stock Holding History

Beryl Capital Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,076,894	Closed	-$6.3M	–	41
2019 Q1	$6.3M	Buy	+1,076,894	New	+$3.67M	1.16%	12

Beryl Capital Management's IMDZ Position: Q2 2019 in Review

Beryl Capital Management sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 1,076,894 shares — an estimated $6.3M sold.

Beryl Capital Management first reported a position in IMDZ in Q1 2019 and held it in 1 quarter. The position peaked at $6.3M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Beryl Capital Management reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Beryl Capital Management sold 1,076,894 Immune Design Corp. shares in Q2 2019, an estimated $6.3M.
Beryl Capital Management first reported a position in Immune Design Corp. in Q1 2019 and held it in 1 quarter.
Beryl Capital Management's Immune Design Corp. position peaked at $6.3M in Q1 2019.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Beryl Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.